ArticleClinical and experimental medicine2022

Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination.

Davide Firinu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.